Sidsel H. Stoy
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Dynamics in Circulating Immune Cell Subsets After Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Journal: Clinical and translational gastroenterology
Published: August 27, 2025
Role of Intestinal Microbiome in Potentiating Inflammation and Predicting Outcomes in Alcohol-Associated Cirrhosis.
Journal: Gastroenterology clinics of North America
Published: May 10, 2025
Lipidated interleukin-22 reduces body weight and spares lean mass in mice by a novel gut-acting mechanism additive to GLP-1 agonism.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 04, 2025
Cirrhosis and Faecal microbiota Transplantation (ChiFT) protocol: a Danish multicentre, randomised, placebo-controlled trial in patients with decompensated liver cirrhosis.
Journal: BMJ open
Published: February 12, 2025
Lipidated IL-22 Alone or Combined with Immunomodulatory Agents Improves Disease Endpoints and Promotes Mucosal Healing in a Mouse Model of Chronic Dextran Sodium Sulfate-Induced Colitis.
Journal: Digestive diseases and sciences
Published: January 20, 2025
Incidence and mortality of alcohol-related hepatitis in Denmark - an update, 2016-2023.
Journal: JHEP reports : innovation in hepatology
Published: December 03, 2024
The FGL-1/LAG-3 Axis is Associated With Disease Course in Alcohol-associated Hepatitis: A Preliminary Report.
Journal: Journal of clinical and experimental hepatology
Published: November 27, 2023
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection - Authors' reply.
Journal: The lancet. Gastroenterology & hepatology
Published: November 30, 2022
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial.
Journal: The lancet. Gastroenterology & hepatology
Published: July 25, 2022
Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis.
Journal: Clinical and experimental gastroenterology
Published: August 12, 2021
Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial.
Journal: Journal of hepatology
Published: March 19, 2021
Interferon lambda 4 genotype and pathway in alcoholic hepatitis.
Journal: Scandinavian journal of gastroenterology
Published: February 19, 2021
Last Updated: 09/26/2026